Top Vaccines companies in South Korea by Total Non-Current Liabilities

This ranking features the top 21 Vaccines companies in South Korea ranked by Total Non-Current Liabilities, totaling a Total Non-Current Liabilities of USD 1.26 B, for February 04, 2025.
#
Name
Total Non-Current Liabilities
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 263.39 M
Dec. 31, 2023 USD 9.61 -3.70%

South Korea

2
USD 246.65 M
Dec. 31, 2023 USD 119.86 -2.20%

South Korea

3
USD 231.07 M
Dec. 31, 2023 USD 65.38 -0.04%

South Korea

4
USD 180.12 M
Dec. 31, 2023 USD 88.80 -5.65%

South Korea

5
USD 104.79 M
Dec. 31, 2023 USD 89.76 -4.42%

South Korea

6
USD 45.24 M
Dec. 31, 2023 USD 15.77 -2.26%

South Korea

7
USD 35.27 M
Dec. 31, 2023 USD 10.77 -3.15%

South Korea

8
USD 32.47 M
Dec. 31, 2023 USD 1.61 -1.19%

South Korea

9
USD 32.12 M
Dec. 31, 2023 USD 8.83 4.03%

South Korea

10
USD 19.32 M
Dec. 31, 2023 USD 3.04 -3.81%

South Korea

11
USD 12.79 M
Dec. 31, 2023 USD 1.42 -2.25%

South Korea

12
USD 10.06 M
Dec. 31, 2023 USD 3.29 -3.64%

South Korea

13
USD 9.96 M
Dec. 31, 2023 USD 32.21 -3.61%

South Korea

14
USD 8.13 M
Dec. 31, 2023 USD 77.77 -3.69%

South Korea

15
USD 7.67 M
Dec. 31, 2023 USD 11.62 -0.90%

South Korea

16
USD 7.03 M
Dec. 31, 2023 USD 1.65 -4.10%

South Korea

17
USD 6.02 M
Dec. 31, 2023 USD 240.05 -5.25%

South Korea

18
USD 4.48 M
Dec. 31, 2023 USD 1.23 -3.88%

South Korea

19
USD 1.97 M
Dec. 31, 2023 USD 4.40 -2.27%

South Korea

20
USD 1.40 M
Dec. 31, 2023 USD 2.33 -4.21%

South Korea

21
USD 840.49 K
Dec. 31, 2023 USD 3.75 -3.31%

South Korea

Frequently Asked Questions
  • Which Vaccines company in South Korea has the highest Total Non-Current Liabilities ?

    The Vaccines company in South Korea with the highest Total Non-Current Liabilities is Green Cross Holdings Corporation (KSE: 005250.KS) at USD 263.39 M.

  • Which Vaccines company in South Korea has the lowest Total Non-Current Liabilities ?

    The Vaccines company in South Korea with the lowest Total Non-Current Liabilities is iNtRON Biotechnology, Inc. (KOSDAQ: 048530.KQ) at USD 840.49 K.

SV Wall Street